GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (STU:NOV) » Definitions » Shiller PE Ratio

Novo Nordisk A/S (STU:NOV) Shiller PE Ratio : 82.01 (As of May. 10, 2024)


View and export this data going back to . Start your Free Trial

What is Novo Nordisk A/S Shiller PE Ratio?

As of today (2024-05-10), Novo Nordisk A/S's current share price is €119.74. Novo Nordisk A/S's E10 for the quarter that ended in Mar. 2024 was €1.46. Novo Nordisk A/S's Shiller PE Ratio for today is 82.01.

The historical rank and industry rank for Novo Nordisk A/S's Shiller PE Ratio or its related term are showing as below:

STU:NOV' s Shiller PE Ratio Range Over the Past 10 Years
Min: 25.12   Med: 39.48   Max: 88.29
Current: 82.75

During the past years, Novo Nordisk A/S's highest Shiller PE Ratio was 88.29. The lowest was 25.12. And the median was 39.48.

STU:NOV's Shiller PE Ratio is ranked worse than
81.46% of 151 companies
in the Biotechnology industry
Industry Median: 35.74 vs STU:NOV: 82.75

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novo Nordisk A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.762. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €1.46 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novo Nordisk A/S Shiller PE Ratio Historical Data

The historical data trend for Novo Nordisk A/S's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Shiller PE Ratio Chart

Novo Nordisk A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.10 31.03 47.09 52.82 68.12

Novo Nordisk A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.40 57.81 64.72 68.12 82.57

Competitive Comparison of Novo Nordisk A/S's Shiller PE Ratio

For the Biotechnology subindustry, Novo Nordisk A/S's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk A/S's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's Shiller PE Ratio falls into.



Novo Nordisk A/S Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novo Nordisk A/S's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=119.74/1.46
=82.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Nordisk A/S's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Novo Nordisk A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.762/116.7000*116.7000
=0.762

Current CPI (Mar. 2024) = 116.7000.

Novo Nordisk A/S Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.178 99.700 0.208
201409 0.166 99.700 0.194
201412 0.169 99.400 0.198
201503 0.254 100.200 0.296
201506 0.217 100.300 0.252
201509 0.219 100.200 0.255
201512 0.217 99.800 0.254
201603 0.249 100.200 0.290
201606 0.263 100.600 0.305
201609 0.260 100.200 0.303
201612 0.233 100.300 0.271
201703 0.273 101.200 0.315
201706 0.270 101.200 0.311
201709 0.266 101.800 0.305
201712 0.226 101.300 0.260
201803 0.295 101.700 0.339
201806 0.286 102.300 0.326
201809 0.251 102.400 0.286
201812 0.237 102.100 0.271
201903 0.292 102.900 0.331
201906 0.270 102.900 0.306
201909 0.287 102.900 0.325
201912 0.248 102.900 0.281
202003 0.338 103.300 0.382
202006 0.304 103.200 0.344
202009 0.297 103.500 0.335
202012 0.270 103.400 0.305
202103 0.366 104.300 0.410
202106 0.354 105.000 0.393
202109 0.354 105.800 0.390
202112 0.320 106.600 0.350
202203 0.418 109.900 0.444
202206 0.394 113.600 0.405
202209 0.426 116.400 0.427
202212 0.405 115.900 0.408
202303 0.590 117.300 0.587
202306 0.580 116.400 0.581
202309 0.670 117.400 0.666
202312 0.659 116.700 0.659
202403 0.762 116.700 0.762

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novo Nordisk A/S  (STU:NOV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novo Nordisk A/S Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk A/S (STU:NOV) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S (STU:NOV) Headlines